A total of 25 patients at 24 hours and 17 patients at 7 days had both baseline and follow-up NIHSS scores of 1, which met the definition of major neurologic improvement; reclassifying these ...

Subgroup analyses were prespecified for the primary outcome according to age (≤70 or >70 years), dichotomous baseline NIHSS score (6 to 20 or >20), baseline NIHSS score (6 to 9, 10 to 20, or >20 ...

TASTE-1 enrolled acute stroke patients with a median baseline National Institutes of Health Stroke Scale (NIHSS) score of 6. They did not receive reperfusion therapy.

The mean baseline NIHSS score was 7 in both groups, and the symptom-onset-to-needle time was similar at 180 minutes for the tenecteplase group and 178.5 minutes for the alteplase group.

Standardization: The NIHSS provides a standardized and objective assessment of stroke severity. This allows healthcare professionals to compare scores over time, which can help guide treatment ...

The median time from stroke onset to randomization was 4.6 hours. The median NIHSS score was 2. The primary outcome was a return to baseline neurological functioning according to the mRS score at 90 ...

Investigators randomized 832 patients (median age 69 years; 64% men) to receive IV tirofiban or placebo on top of systemic thrombolysis. At baseline, median NIHSS score was 6 and median ASPECTS was 10 ...

The rate of NIH Stroke Scale (NIHSS) score increase of at least 2 points during that period was just 2.22% with the zero-degree head position compared with 55.32% in the heads-up group (P<0.001 ...